New DBS device for Parkinson’s approved for US patients

News

Author: AdminPublished: 24 June 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The US Food and Drug Administration (FDA) has approved a new implantable deep brain stimulation device (DBS) called the Brio Neurostimulation System.

Previously the Activa DBS Therapy System manufactured by Medtronic was the only device available to patients in the US.

Like the Activa system, the newly approved Brio system consists of a battery-powered rechargeable electrical pulse generator that is inserted under the skin of the upper chest and wires that lead to electrodes implanted in the brain.

The new Brio system is made by St. Jude Medical.

Go Back

Share this story

Comments


Related articles


Law office lawyers working with hammers and scales with contract documents with legal tiger skins on consultant concept table.

Global update

Introducing the “first-ever” legislation devoted solely to ending Parkinson’s disease

Learn about the US National Plan to End Parkinson’s Act

READ MORE
Marijuana

Global update

The future of Parkinson’s and medicinal plants

The Parkinson’s Foundation hosts leading experts

READ MORE

Advances

Global Parkinson’s study reveals sleep as biggest influence on wellbeing

First insights revealed from data gathered by smartphones

READ MORE